Research and Development
This group unites PF patients, caregivers, researchers and medical professionals in a platform to... View more
EGCG Research Providing Hope for IPF Patients
-
EGCG Research Providing Hope for IPF Patients
Our Pulmonary Fibrosis Forum has been active regarding EGCG and the treatment of IPF. I haven’t commented or replied about the topic and felt I needed more research to reinforce hope for IPF patients. I found an article titled, “The Effects of Epigallocatechin Gallate (EGCG) on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—A Next-Generation Sequencing and Bioinformatic Approach.” The article appeared in the International Journal of Molecular Sciences.
The verbiage in the article is heavily laden with medical vocabulary. I used an online dictionary when I was reading and I had to refer to it several times . Fortunately, the abstract and conclusion are comprehensible for laypersons.
The authors write, “Epigallocatechin gallate (EGCG) is a polyphenol, which is the major biological component of green tea.” The research is devoted to applying the EGCG component to the fibroblasts. The writers conclude, “Our findings provide a scientific basis to evaluate the potential benefits of EGCG in IPF treatment, and warrant future studies to understand the role of molecular pathways underlying cholesterol homeostasis in the pathogenesis of IPF.”
This research provides hope and reinforcement to the article published in the Pulmonary Fibrosis News regarding EGCG and treating IPF.
Please read the article, it is free. Charlene and I would love to hear what you have to say about this research article.
Log in to reply.